Otsuka Holdings Co. Ltd. | Mutual Funds
Mutual Funds that own Otsuka Holdings Co. Ltd.
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
1.69%
128,000
0.85%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
6,016,300
1.08%
-443,100
0.39%
07/31/2018
Vanguard Total International Stock Index Fund
5,938,166
1.07%
73,400
0.08%
07/31/2018
Government Pension Fund - Global (The)
5,164,559
0.93%
-334,501
0.03%
12/31/2017
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
0.86%
2,000
0.84%
08/20/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
0.76%
-16,000
0.84%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
2,953,000
0.53%
-192,000
0.4%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
2,709,700
0.49%
0
0.4%
08/20/2018
Vanguard Developed Markets Index Fund
2,358,846
0.42%
-2,200
0.1%
07/31/2018
Mitsubishi UFJ MAXIS Nikkei 225 ETF (1346)
2,294,000
0.41%
46,000
0.84%
07/31/2018
| Address |
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
|
|
Employees
|
- |
| Website |
http://www.otsuka.com |
| Updated |
07/08/2019 |
| Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. |
